267 related articles for article (PubMed ID: 23249728)
1. Bioidentical progesterone cream for menopause-related vasomotor symptoms: is it effective?
Whelan AM; Jurgens TM; Trinacty M
Ann Pharmacother; 2013 Jan; 47(1):112-6. PubMed ID: 23249728
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
Ruiz AD; Daniels KR
Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
[TBL] [Abstract][Full Text] [Related]
3. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
4. Bioidentical Oral 17β-Estradiol and Progesterone for the Treatment of Moderate to Severe Vasomotor Symptoms of Menopause.
Woodis CB; Ghassemi E; McLendon AN
Ann Pharmacother; 2021 Sep; 55(9):1153-1158. PubMed ID: 33345556
[TBL] [Abstract][Full Text] [Related]
5. Use of gabapentin for the management of natural or surgical menopausal hot flashes.
Hayes LP; Carroll DG; Kelley KW
Ann Pharmacother; 2011 Mar; 45(3):388-94. PubMed ID: 21343402
[TBL] [Abstract][Full Text] [Related]
6. Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis.
Mohammady M; Janani L; Jahanfar S; Mousavi MS
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():295-302. PubMed ID: 30056356
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women.
Kelley KW; Carroll DG
J Am Pharm Assoc (2003); 2010; 50(5):e106-15. PubMed ID: 20833608
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hot flushes and night sweats: where are we now?
Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
[TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women.
Benster B; Carey A; Wadsworth F; Vashisht A; Domoney C; Studd J
Menopause Int; 2009 Jun; 15(2):63-9. PubMed ID: 19465671
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of compounded bioidentical hormone replacement therapy: an observational cohort study.
Ruiz AD; Daniels KR; Barner JC; Carson JJ; Frei CR
BMC Womens Health; 2011 Jun; 11():27. PubMed ID: 21651797
[TBL] [Abstract][Full Text] [Related]
11. Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound.
Prior JC; Hitchcock CL
Gynecol Endocrinol; 2012 Oct; 28 Suppl 2():7-11. PubMed ID: 22849758
[TBL] [Abstract][Full Text] [Related]
12. Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.
Hitchcock CL; Prior JC
Menopause; 2012 Aug; 19(8):886-93. PubMed ID: 22453200
[TBL] [Abstract][Full Text] [Related]
13. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
Bouchard P; Panay N; de Villiers TJ; Vincendon P; Bao W; Cheng RJ; Constantine G
Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
Utian WH
Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
[TBL] [Abstract][Full Text] [Related]
15. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
Holtorf K
Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
[TBL] [Abstract][Full Text] [Related]
16. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women.
Stevens RE; Hanford K; Wason S; Cusack SL; Phelps KV
Int J Fertil Womens Med; 2000; 45(4):264-72. PubMed ID: 10997482
[TBL] [Abstract][Full Text] [Related]
17. A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause.
Archer DF; Bernick BA; Mirkin S
Expert Rev Clin Pharmacol; 2019 Aug; 12(8):729-739. PubMed ID: 31282768
[No Abstract] [Full Text] [Related]
18. Nonestrogen treatment modalities for vasomotor symptoms associated with menopause.
Fugate SE; Church CO
Ann Pharmacother; 2004 Sep; 38(9):1482-99. PubMed ID: 15292498
[TBL] [Abstract][Full Text] [Related]
19. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
20. Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.
Cortés-Bonilla M; Bernardo-Escudero R; Alonso-Campero R; Francisco-Doce MT; Hernández-Valencia M; Celis-González C; Márquez-Oñate R; Chedraui P; Uribe JA
Gynecol Endocrinol; 2015 Jul; 31(7):552-9. PubMed ID: 26062108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]